NCT02251847View on ClinicalTrials.gov

The Efficacy and Safety of a Combination Therapy of Rosuvastatin and Ezetimibe Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients

PHASE3UnknownINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

July 31, 2015

Conditions
Hypercholesterolemia
Interventions
DRUG

Rosuvastatin/Ezetimibe

Rosuvastatin 5mg

Trial Locations (1)

Unknown

RECRUITING

Gil Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

IlDong Pharmaceutical Co Ltd

INDUSTRY

NCT02251847 - The Efficacy and Safety of a Combination Therapy of Rosuvastatin and Ezetimibe Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients | Biotech Hunter | Biotech Hunter